#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Idiopathic inflammatory myopathy Fusarium infection Rett syndrome Aicardi-Goutieres syndrome Li-Fraumeni syndrome Myeloid leukaemia Sarcoma Ovarian cancer Orthostatic hypotension Hypochondroplasia Hyperchylomicronaemia Cervix carcinoma Hepatitis B Mucopolysaccharidosis II Hepatic angiosarcoma More trials…
Learn about Rare Diseases

Rhabdomyosarcoma recurrent – Basic Information X-linked lymphoproliferative syndrome – Treatment Hereditary ataxia Alveolar rhabdomyosarcoma Medulloblastoma – Treatment Crigler-Najjar syndrome Primary mediastinal large B-cell lymphoma Arterial tortuosity syndrome – Basic Information Gaucher’s disease type III – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Acoramidis Ginisortamab Prx005 Zofenopril Calcium Cariprazine Simoctocog Alfa Upacicalcet Sodium Hydrate Emavusertib Hydroxyzine Hydrochloride Tozorakimab Efgartigimod Alfa Ripretinib (-)-PHENSERINE TARTRATE PARECOXIB ARI0008 64Cu-Dota-Ae105 Melatonin Img-007 Anv600 Avacopan More therapies…

Learn about Your Condition

Hyperglycaemia Uterine leiomyosarcoma Affective disorder Arrhythmia supraventricular Pouchitis Staphylococcal bacteraemia Urticaria chronic Encephalitis autoimmune Hepatic adenoma Intestinal infarction Oesophageal food impaction Primary adrenal insufficiency Cardiac sarcoidosis Mesothelioma malignant Anxiety More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Burkitt’s lymphoma

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Burkitt’s lymphoma
Investigated Drugs:
Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies

Not recruiting

1 1 1
Investigated Diseases:
Investigated Drugs:
- Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Burkitt’s lymphoma
Investigated Drugs:
+1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Burkitt’s lymphoma

Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

Study on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies

Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies